Study Design Systematic review. Clinical Questions (1) Is autologous local bone (LB) graft as safe and effective as iliac crest bone graft (ICBG) in lumbar spine fusion? (2) In lumbar fusion using ICBG, does a single-incision midline approach reduce postoperative iliac crest pain compared with a two-incision traditional approach? Methods Electronic databases and reference lists of key articles were searched up to October 2014 to identify studies reporting the comparative efficacy and safety of ICBG versus LB graft or comparing ICBG harvest site for use in lumbar spine surgery. Studies including allograft, synthetic bone, or growth factors in addition to ICBG and those with less than 80% of patients with degenerative disease in the lumbar spine were excluded. Two independent reviewers assessed the level of the evidence quality using the Grades of Recommendation Assessment, Development and Evaluation criteria, and disagreements were resolved by consensus. Results Seven studies were identified as using ICBG fusion for degenerative disease in the lumbar spine. There were no differences in the fusion, leg pain, low back pain, or functional outcomes between patients receiving LB versus ICBG. There was a higher incidence of donor site pain and sensory loss in patients receiving ICBG, with no donor site complications attributed to LB. Compared with patients with the graft harvested through the two-incision traditional approach, patients with the graft harvested through the single-incision midline approach had lower mean pain scores over the iliac crest, with a higher proportion reporting no iliac crest tenderness. In patients with ICBG harvested through the single-incision midline approach on either the right or the left side of the ilium, only 36% of the patients were able to correctly identify the side when asked whether they knew which iliac crest was harvested. Only 19% of the patients with ICBG harvested through the single-incision midline approach on either the right or
Study Rationale and Context
Solid bone fusion is the primary goal of all fusion procedures for lumbar degenerative disease. Autologous iliac crest bone has long been considered the gold standard for these fusion procedures. However, there are recognized drawbacks to depending on iliac crest bone graft (ICBG), including increased operative time, increased blood loss, increased donor site morbidity, and a limitation to the amount that can be realistically harvested for multilevel fusion. There are alternatives for "expanding" the amount of ICBG including aspiration systems; however, this option potentially substantially increases the cost of these procedures and the aspirations are not as enriched with osteoinductive elements as harvested iliac crest marrow. The other readily available autologous bone source in these fusion procedures is local bone (LB) graft harvested at the time of decompression, which is often referred to as "bad bone" by many surgeons compared with the "good bone" of ICBG. However, there is growing interest and supportive evidence for the utilization of LB alone or in combination with ICBG or other bone extenders as the primary fusion substrate, which is especially true for shorter segment fusions; the practice requires efficient harvest of all available LB as opposed to using the drill primarily for the decompression. It also involves a meticulous preparation of the harvested bone including removal of soft tissue elements and morselization to increase the surface area for fusion. In addition, regardless of the fusion substrate, there is no substitution for meticulous preparation of the fusion bed before placement of the fusion substrate. The first systemic review question is designed to address the utilization of LB graft compared with ICBG.
When the decision is made to use ICBG, there are numerous methods described to reduce donor site morbidity, including persistent pain, which is a major concern. One of the fundamental questions is whether to harvest the crest through the same midline incision used for the primary procedure or to use a separate incision. There are advocates and arguments for both procedures including cosmesis, fewer incisions (same incision), less soft tissue undermining and dead space, and better closure of the fascia overlying the crest (separate incisions). The second systemic review question is designed to address these issues.
Clinical Questions
1. Is autologous LB graft as safe and effective as ICBG in lumbar spine fusion? 2. In lumbar fusion using ICBG, does a single-incision midline approach reduce postoperative iliac crest pain compared with a two-incision traditional approach? the left side of the ilium reported pain that was concordant with the side that was actually harvested.
Materials and Methods
Conclusions LB is as safe and efficacious as ICBG for instrumented fusion in the lumbar spine to treat degenerative disease. When ICBG is used, graft harvest through the singleincision midline approach reduces postoperative iliac crest pain compared with a twoincision approach.
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Results
• We identified seven comparative studies that met the inclusion criteria (►Fig. 1). A list of excluded studies can be found in the online supplementary material.
• Three studies compared fusion for degenerative disease in the lumbar spine with either autologous LB or autologous ICBG, one randomized controlled trial (RCT) 2 and two retrospective cohorts 3-5 (►Table 1).
• Four studies, one RCT 6 and three retrospective cohorts, 7-9 evaluated the origin of donor site morbidity in the lumbar spine using autologous ICBG. Of these, two studies compared the single-incision midline approach with the two-incision traditional approach. 6, 7 The other two studies evaluated whether patients were able to correctly identify the side of harvest site based on pain (►Table 2).
8,9
Local Bone versus Iliac Crest Bone Graft for Fusion in the Lumbar Spine
• There were no differences in fusion, leg pain, low back pain, or functional outcomes between the patients receiving LB or ICBG in one RCT and two retrospective cohorts (►Table 3).
2,4,5
• In the patients receiving LB versus ICBG, there was a higher incidence of donor site pain (0 versus 15%, respectively, p ¼ 0.025) and sensory loss (0 versus 20%, respectively, p ¼ 0.01) (►Table 4).
• There were no donor site complications attributed to LB grafting (►Table 4).
4,5
• There were no differences between the treatment groups with respect to complications not related to the donor site, such as infection, dural tears, pedicle screw misplacement, or instrumentation failure (►Table 5).
2,4,5
Origin of Graft Site Morbidity in Patients Receiving ICBG for Fusion in the Lumbar Spine
Midline versus Traditional Approach
• Patients with graft harvested through the single-incision midline approach had lower mean pain scores over the iliac crest compared with those patients with graft harvested through the two-incision traditional approach (0.25 versus 2, respectively, p < 0.0001), 6 with a higher proportion reporting no iliac crest tenderness (82.1 versus, 45.1%, respectively; ►Figs. 2 and 3).
7
• A higher proportion of the patients having grafts harvested through the single-incision midline approach were satisfied with the graft procedure and cosmesis than the patients with grafts harvested through the two-incision traditional approach (96.5 versus 81.3%, p < 0.5).
6
• No statistical difference in complications (sacroiliac penetration, donor site pain > 1 year, residual donor site numbness, seroma, temporary sensory loss, donor site pain >30 days, reoperation, or surgical complications) was found between the single-incision midline approach and the two-incision traditional approach for graft harvest (►Table 6).
Right versus Left Side Harvest Site
• In the patients with ICBG harvested through the singleincision midline approach on either the right or the left side of the ilium, only 36% of the patients were able to correctly identify the side when asked whether they knew which iliac crest was harvested. Of these, only 8% had confidence in their answer (►Fig. 4).
9
• Only 19% of the patients with ICBG harvested through the single-incision midline approach on either the right or the left side of the ilium reported pain that was concordant with the side that was actually harvested (i.e., right side harvest site, right side pain reported; ►Fig. 4).
8
• When comparing patients receiving lumbar fusion without ICBG (rhBMP-2 used) with the patients with ICBG harvested through the single-incision midline approach, there was no difference in the proportion of patients reporting pain or tenderness (50.8 versus 56.6%, respectively; ►Fig. 4).

Clinical Guidelines
None found.
Evidence Summary
• There was no difference in effectiveness or safety in lumbar fusion comparing ICBG with LB grafts (►Table 7).
The strength of the evidence for this conclusion was very low.
• There was less pain and tenderness over the iliac crest harvest site when a single-incision midline approach was used compared with a two-incision traditional approach in lumbar fusion (►Table 8). The strength of evidence for this conclusion was very low. • Local bone graft (spinal processes of L4-L5 and lamina between L4-L5) (structural) Control:
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• Low back and neck pain for • Local bone graft (morselized from laminectomy)
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• Age • Local bone graft (obtained from decompression and morselized) Control:
• Age ¼ 60 y Control:
• Age ¼ 60 y Total:
• Decompression: 2þ levels 45%
• Fusion: 2þ levels 33%
Inclusion:
• NR Exclusion:
• NR ! 24 mo (mean 28, range: 24-72 mo), 76/109 (68%)
• Stenosis (61%)
• Degenerative spondylolisthesis with stenosis (16%)
• Isthmic spondylolisthesis with disk degeneration (16%)
• Degenerative scoliosis (>20 degrees) with stenosis (7%)
• Previous spine surgery (28%) • n ¼ 58
• Age ¼ 48 y Control:
• Age ¼ 51 y Inclusion:
• NR 2 y; % NR Diagnosis:
• Degenerative disease (100%) Fusion:
• Decompression with PLIF (instrumented)
Graft:
• Cancellous bone chips and strips (outer 
• Age ¼ 41.8 y Control:
• Age ¼ 43.7 y Inclusion:
• Follow-up of at least 1 year Exclusion:
• NR • Degenerative disease or trauma (% NR) Fusion:
• From L3 or lower to L5 or S1
• Either index fusion surgery or fusion as a part of a decompression and instrumentation procedure Graft:
• NR • n ¼ 53 Control:
• n ¼ 59
• NR Exclusion: • Instrumented posterolateral fusion at 1 or 2 levels Graft:
• Excised by midline approach (outer table tech • ICBG harvested from the right side Control:
• ICBG harvested from the left side
• Agreement to be blinded to the side of harvest and accept reconstruction of the site Exclusion:
• Previous iliac crest harvest
• Refusal of iliac crest grafting • Degenerative disorders (80%)
• Spinal deformity (16%)
• Tumor (4%) Fusion:
• Posterior lumbar arthrodesis (instrumented, with pedicle screw fixation) a Graft:
• Graft was harvested through same midline skin incision but separate fascial incision
• Harvest site was reconstructed with allograft When patients do not improve after lumbar fusion, the question always becomes "Did we achieve adequate fusion?" Fusion cannot be completely evaluated radiographically and is not always associated with outcome, but continues to be our ultimate goal. The choices of fusion substrate are numerous but fiscal restraints and long-term efficacy/ safety studies would still argue that an autologous source would be ideal. We have tried to address the issue of safety and efficacy with autologous sources (local autograft versus ICBG) in the available literature. This issue is especially pertinent in shorter-segment fusions and fortunately the available studies that met the screening criteria all involved short-segment fusions for degenerative disease. Based on the available evidence, the LB graft is a reasonable alternative to ICBG for single-level instrumented fusions Abbreviations: ICBG, iliac crest bone graft; NS, not specified. for lumbar degenerative disease at a very low evidence level.
Weaknesses of this study include that there were only three studies that met the criteria for inclusion, of which one was an RCT (level 2) and two were retrospective cohort studies (level 3). All of the studies used interbody fusion and posterior instrumentation, and so it is harder to extrapolate to posterolateral fusions in addition to instrumentation or noninstrumented fusions. The RCT had relatively small numbers and no report of percent follow-up. The two cohort studies had no percentage follow-up in one and 68% followup in the other. These factors contribute to a very low When the decision is made to harvest ICBG, consideration must be given to reducing donor site morbidity, including long-term pain, which is a major factor. There is considerable surgeon variability with regard to harvesting ICBG including the use of one incision or two incisions. Two studies met the screening process and addressed the choice of incisions specifically: one RCT (level 2) and one retrospective cohort studies (level 3). One cohort study looked at ICBG harvest versus no harvest (bone morphogenetic protein) and one study had the patients blinded to the side of harvest through a separate incision and patients underwent reconstruction of the defect at the time of harvest. At a very low level of evidence, there was less pain over the iliac crest harvest site, better patient satisfaction, and comparable complication rates for graft harvested through the midline incision. There was also a low concordance rate for correctly identifying the side of iliac crest harvest when it was harvested through the midline incision. Based on the available literature, harvesting graft through the same midline incision may be a better option than a using a separate incision. Again, this review was based on a relatively small number of low-to moderate-quality studies available in the literature. 
